# Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass

> **NCT02122679** · PHASE4 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Heart Defect, Congenital

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02122679
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02122679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02122679, "Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02122679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*